FDA Brief

Warning letters Drugs

FDA warning letter to

GLP-1 Solution

Issued Sep 9, 2025Posted Sep 16, 2025Center for Drug Evaluation and Research (CDER)

Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth). We haven't summarized this letter yet. Read it on fda.gov.